TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $50
Astrana Health Inc.
Astrana Health Inc. ASTH | 0.00 |
TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:
ASTH) with a Buy and raises the price target from $45 to $50.
